seed
Stage
1
Investors
About
Ferrosa Therapeutics AG develops biologic therapies targeting anemia of inflammation associated with chronic kidney disease, cancer, and autoimmune disorders by addressing inflammatory pathways that cause treatment resistance.
Explore Ferrosa Therapeutics AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.